Results 131 to 140 of about 5,439,025 (359)
ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma
Molecular Oncology, EarlyView.In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee +9 more
wiley +1 more source
PLOS Global Public Health[This corrects the article DOI: 10.1371/journal.pgph.0001362.].
PLOS GLOBAL PUBLIC HEALTH Staff
doaj +1 more source
Current status of the Global Cancer Control Program of the World Health Organization
, 1993 Jan Stjernswärd, Noreen Teoh
openalex +1 more source
National and Global Health Law: A Scholarly Examination of the Most Pressing Health Hazards [PDF]
, 2008 The health of individuals, families, and communities has deep, intuitive meaning. So much of what we aspire to be as individuals or as members of society relies on health.
Gostin, Lawrence O.
core +1 more source
Molecular Oncology, EarlyView.Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan +4 more
wiley +1 more source
Amplifying the global issue of hearing loss
The Lancet Global Health, 2022 The Lancet Global Health
doaj
Global considerations affecting the health agenda of the 1990s
, 1992 Margaret Catley‐Carlson
openalex +1 more source